Bristol Myers Squibb Co (BMY): who owns it and who trades it
As of Nov 16, 2026, BMY insiders reported 5 open-market sales worth $2.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was David V Elkins (CFO), with $1.9M. 10 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Bristol Myers Squibb
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns BMY
2,507 funds and institutions reported BMY shares worth $96.2B at the end of Q2 2026, about 82% of the company. The largest holder is BlackRock, Inc. with 8.8%.
Funds and institutions (13F) 82%Everyone else 18%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 180.38M | 8.83% | $10.4B | +5% |
| Vanguard Capital Management LLC | 133.34M | 6.53% | $7.7B | +1% |
| State Street Corp | 102.41M | 5.01% | $5.9B | +4% |
| JPMorgan Chase & Co | 71.71M | 3.51% | $4.2B | – |
| Charles Schwab Investment Management Inc | 67.60M | 3.31% | $3.9B | +11% |
| Geode Capital Management, LLC | 56.44M | 2.76% | $3.2B | +2% |
| Vanguard Portfolio Management LLC | 46.87M | 2.30% | $2.7B | +1% |
| Norges Bank | 36.87M | 1.81% | $2.1B | – |
| Bank of America Corp | 34.05M | 1.67% | $2B | +4% |
| T. Rowe Price Associates | 31.71M | 1.55% | $1.8B | +209% |
| Morgan Stanley | 29.01M | 1.42% | $1.7B | -1% |
| AQR Capital Management LLC | 27.36M | 1.34% | $1.6B | -8% |
| Ameriprise Financial Inc | 26.67M | 1.31% | $1.5B | +1% |
| Primecap Management Co | 24.92M | 1.22% | $1.4B | -0% |
| Northern Trust Corp | 24.92M | 1.22% | $1.4B | +1% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 22.84M | 1.12% | $1.3B | +1% |
| Bank of New York Mellon Corp | 21.82M | 1.07% | $1.3B | -6% |
| Independent Franchise Partners LLP | 21.79M | 1.07% | $1.3B | +2% |
| Dimensional Fund Advisors LP | 19.69M | 0.96% | $1.1B | +5% |
| Legal & General Group Plc | 17.02M | 0.83% | $981M | +1% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, BMY insiders reported $0 of open-market purchases and $2.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Julia A Haller | Director | Sale | 3,800 | $63.31 | $241K | Form 4 |
| Sep 9, 2026 | Cristian Massacesi | Vice president | Sale | 6,249 | $64.57 | $403K | Form 4 |
| Aug 25, 2026 | Phil M Holzer | Vice president | Sale | 500 | $67.50 | $33.8K | Form 4 |
| Apr 1, 2026 | David V Elkins | CFO | Sale | 25,519 | $61.60 | $1.6M | Form 4 |
| Apr 1, 2026 | David V Elkins | CFO | Sale | 4,481 | $62.05 | $278K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| David V Elkins | EVP, Chief Financial Officer | – | $1.9M | Apr 1, 2026 |
| Cristian Massacesi | EVP,Chief Med Offr,Head of Dev | – | $403K | Sep 9, 2026 |
| Julia A Haller | Director | – | $241K | Nov 5, 2026 |
| Phil M Holzer | SVP and Controller | – | $33.8K | Aug 25, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BMY short interest
Low short interest. 2.3% of BMY shares are sold short: about 1 share in 44. Over the last 12 reports the number of shares short went up 28%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 46.85M BMY shares were sold short, 2.3% of the shares outstanding, down 6.2% from the report before. At the average daily volume of 11.06M shares, buying them all back would take about 4.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 46.85M | 2.29% | -6% | 11.06M | 4.2 |
| Oct 15, 2026 | 49.95M | 2.45% | +9% | 13.69M | 3.6 |
| Sep 30, 2026 | 45.85M | 2.24% | +9% | 15.25M | 3.0 |
| Sep 15, 2026 | 41.97M | 2.05% | -5% | 7.24M | 5.8 |
| Aug 31, 2026 | 44.07M | 2.16% | -4% | 8.37M | 5.3 |
| Aug 14, 2026 | 45.85M | 2.24% | -12% | 13.18M | 3.5 |
| Jul 31, 2026 | 52.34M | 2.56% | +16% | 11.29M | 4.6 |
| Jul 15, 2026 | 44.94M | 2.20% | +11% | 10.60M | 4.2 |
| Jun 30, 2026 | 40.53M | 1.98% | +2% | 16.38M | 2.5 |
| Jun 15, 2026 | 39.60M | 1.94% | +3% | 11.89M | 3.3 |
| May 29, 2026 | 38.51M | 1.89% | +5% | 11.14M | 3.5 |
| May 15, 2026 | 36.72M | 1.80% | +17% | 10.38M | 3.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded BMY
Since Nov 17, 2024, 9 members of Congress reported 5 purchases and 11 sales of BMY. The latest was a sale by Mike Kelly on May 7, 2026, reported Jun 11, 2026.
Purchases 5Sales 11
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| May 7, 2026 | Mike Kelly (R-PA) | Sale | $15K–$50K | Spouse | Jun 11, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Dec 19, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jan 12, 2026 | Report |
| Dec 18, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Jan 15, 2026 | Report |
| Nov 13, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Dec 11, 2025 | Report |
| Nov 12, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Dec 15, 2025 | Report |
| Oct 9, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Nov 18, 2025 | Report |
| Aug 14, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Sep 11, 2025 | Report |
| Jun 24, 2025 | Virginia Foxx (R-NC) | Sale | $1K–$15K | Self | Jul 3, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| Apr 28, 2025 | Julia Letlow (R-LA) | Sale | $1K–$15K | Self | Jan 13, 2026 | Report |
| Apr 15, 2025 | Tommy Tuberville (R-AL) | Sale | $1K–$15K | Self | May 15, 2025 | Report |
| Apr 1, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | May 14, 2025 | Report |
| Mar 27, 2025 | Greg Landsman (D-OH) | Sale | $1K–$15K | Joint | Apr 8, 2025 | Report |
| Jan 15, 2025 | Julie Johnson (D-TX) | Purchase | $1K–$15K | Joint | Feb 12, 2025 | Report |
| Dec 6, 2024 | Virginia Foxx (R-NC) | Purchase | $1K–$15K | Self | Jan 6, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Bristol Myers Squibb company events
Bristol Myers Squibb filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Jul 30, 2026ResultsReleased financial results. Filing
- May 8, 2026VoteReported shareholder vote results. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Feb 5, 2026ResultsReleased financial results. Filing
- Jan 12, 2026AnnouncementShared information with investors. Filing
- Nov 18, 2025AnnouncementBristol-Myers Squibb Company issued a press release announcing the early participation results, amendment and early settlement of its previously announced cash tender offers to purchase notes issued by Bristol Myers Squibb. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Bristol Myers Squibb makes money
Legacy Brands brought in 45% of Bristol Myers Squibb's revenue ($21.8B of $48.2B) in 2025. Orencia was next, at 8%.
By product or service, 2025
By region, 2025
From Bristol Myers Squibb's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 11, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Bristol Myers Squibb financials
Famous investors that hold BMY
10 of the 50 well-known investors we track reported holding BMY in their latest 13F filing. The largest position is Richard Pzena's, worth $889M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Richard Pzena · Pzena Investment Management | Q3 2026 | 14.24M | $889M | 2.6% | -16% |
| Israel Englander · Millennium Management | Q3 2026 | 2.20M | $137M | 0.1% | +193% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.14M | $71.3M | 0.0% | -27% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 1.03M | $64.5M | 0.3% | New |
| Jeremy Grantham · GMO | Q3 2026 | 463,660 | $28.9M | 0.1% | +13% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 213,131 | $13.3M | 0.0% | +23% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 77,808 | $4.9M | 0.0% | New |
| Bill Miller · Miller Value Partners | Q3 2026 | 69,500 | $4.3M | 0.9% | No change |
| Lee Ainslie · Maverick Capital | Q3 2026 | 34,008 | $2.1M | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 18,200 | $1.1M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Bristol Myers Squibb Co (BMY) stock
Who owns the most BMY stock?
The largest reported owner of Bristol Myers Squibb Co (BMY) is BlackRock, Inc., with 8.8% of the company. In total, 2,507 funds and institutions reported holding BMY at the end of Q2 2026, together about 82% of the shares. See the largest owners.
Are BMY insiders buying or selling?
In the last 12 months, BMY insiders reported no open-market purchases and 5 sales worth $2.5M. The latest trade was on Nov 5, 2026. See every trade.
What is the short interest in BMY?
As of Oct 30, 2026, 46.85M BMY shares were sold short, 2.3% of the shares outstanding, down 6.2% from the report before. At the average daily volume of 11.06M shares, buying them all back would take about 4.2 trading days (days to cover). See the history.
Have members of Congress traded BMY?
Yes. 9 members of Congress reported 5 purchases and 11 sales of BMY since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
How does Bristol Myers Squibb make money?
Legacy Brands brought in 45% of Bristol Myers Squibb's revenue ($21.8B of $48.2B) in 2025. Orencia was next, at 8%. See the full split.
Which famous investors hold BMY?
10 of the 50 well-known investors we track reported BMY in their latest 13F filing, including Richard Pzena, Israel Englander, Ken Griffin. The largest position is worth $889M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.